Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | METAP1 | P53582 | 2/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.37 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10792235 | 0.92 | ALDH1A1 (0.50) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL125602 | 0.90 | ALDH1A1 (0.61) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL29829120 | 0.90 | ALDH1A1 (0.61) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL5544641 | 0.88 | KDM4E (0.42) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL28639550 | 0.88 | ALDH1A1 (0.59) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL17025412 | 0.88 | BLM (0.51) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL11182451 | 0.84 | ALDH1A1 (0.41) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL13911834 | 0.84 | KDM4E (0.38) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL7978914 | 0.83 | HPGD (0.39) | ALDH1A1KDM4EMEN1HPGDKMT2A | |
| SCHEMBL13199308 | 0.81 | KDM4E (0.51) | ALDH1A1KDM4EMEN1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9090819-B2 | Organic electroluminescent element, display device, illuminating device and condensed polycyclic heterocyclic compound | Konica Minolta, Inc. (JP) | 2015-07-28 | — | — | US | disclosed |
| US-9090819-B2 | Organic electroluminescent element, display device, illuminating device and condensed polycyclic heterocyclic compound | Konica Minolta, Inc. (JP) | 2015-07-28 | — | — | US | disclosed |
| US-20120085997-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20120085997-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120085997-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, ILLUMINATING DEVICE AND CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUND | CCNE2, C1S, SCO2 | ALDH1A1 177/4885KDM4E 2552/4885MEN1 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.